Attached files
file | filename |
---|---|
EX-10.12 - EX-10.12 - Regulus Therapeutics Inc. | d842033dex1012.htm |
EX-10.14 - EX-10.14 - Regulus Therapeutics Inc. | d842033dex1014.htm |
EXCEL - IDEA: XBRL DOCUMENT - Regulus Therapeutics Inc. | Financial_Report.xls |
EX-32.1 - EX-32.1 - Regulus Therapeutics Inc. | d842033dex321.htm |
EX-31.2 - EX-31.2 - Regulus Therapeutics Inc. | d842033dex312.htm |
EX-23.1 - EX-23.1 - Regulus Therapeutics Inc. | d842033dex231.htm |
10-K - 10-K - Regulus Therapeutics Inc. | d842033d10k.htm |
EX-31.1 - EX-31.1 - Regulus Therapeutics Inc. | d842033dex311.htm |
EX-10.15 - EX-10.15 - Regulus Therapeutics Inc. | d842033dex1015.htm |
Exhibit 10.16
Regulus Therapeutics Inc.
David L. Szekeres Yearly Discretionary Base Salary Increase
The Board of Directors (the Board) of Regulus Therapeutics Inc., upon the recommendation of the Compensation Committee of the Board, approved the increase of Mr. Szekeress annual base salary to $303,267, effective January 1, 2015.